Mobile Directly Observed Therapy: Monitoring and Improving Hydroxyurea Adherence in Pediatric Sickle Cell Patients
Creary S, Gladwin M, Krishnamurti L. Mobile Directly Observed Therapy: Monitoring and Improving Hydroxyurea Adherence in Pediatric Sickle Cell Patients. Blood 2012, 120: 2060. DOI: 10.1182/blood.v120.21.2060.2060.Peer-Reviewed Original ResearchSickle cell diseaseMedication possession ratioPediatric sickle cell diseaseLaboratory markersPediatric sickle cell patientsMorisky Medication Adherence ScaleAcute chest syndromeFrequent pain crisesHemoglobin F percentageHemoglobin SS diseasePrescription refill recordsMedication Adherence ScaleAnti-tuberculosis therapyPoor medication adherenceLarge clinical trialsRed blood cell disordersSelf-reported adherenceSickle cell patientsBlood cell disordersDOT participantsHU adherenceChest syndromePain crisisMedication ingestionPossession ratioFeasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients
Cohen A, Krishnamurti L, Creary S. Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients. Blood 2012, 120: 3538. DOI: 10.1182/blood.v120.21.3538.3538.Peer-Reviewed Original ResearchAcute lymphoblastic leukemiaMedication adherenceMaintenance therapyAdherence surveyAdherence ratesHealthcare workersPediatric sickle cell populationMaintenance therapy phaseMedication adherence surveyWeekly oral methotrexateDisease-free survivalAnti-retroviral therapyPediatric leukemia patientsHigher adherence ratesNon-adherence ratesRisk of relapseSelf-reported adherenceCommon pediatric cancerSickle cell populationEnd of studyGood overall adherenceYears of ageIntravenous vincristineMMAS-4Month regimen